Article Text

other Versions

PDF
Determination of content uniformity of busulfan capsules by liquid chromatography–mass spectrometry
  1. Thomas E Mürdter1,
  2. Dorothea U Schulze2,
  3. Matthias Schwab1,3,
  4. Siegfried Klumpp2
  1. 1Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology and University Tuebingen, Stuttgart, Germany
  2. 2Apotheke, Robert-Bosch-Krankenhaus, Stuttgart, Germany Department of Clinical Pharmacology, University Hospital Tuebingen, Tuebingen, Germany
  3. 3Department of Clinical Pharmacology, University Hospital Tuebingen, Tuebingen, Germany
  1. Correspondence to Dr D U Schulze, Robert-Bosch-Krankenhaus, Apotheke, Auerbachstr 110, 70376, Stuttgart, Germany; dorothea.schulze{at}rbk.de

Abstract

Study objectives Oral high dose busulfan (1,4-butanediol dimethanesulfonate) is frequently used in conditioning regimens prior to haematopoietic stem cell transplantation. As tablets with high dose busulfan are not commercially available, it is common practice to extemporaneously prepare capsules in hospital pharmacies. However, proper content uniformity assays are lacking.

Methods An HPLC–mass spectrometry (MS) method that was previously validated for quantification of plasma levels of busulfan was adapted for determination of the content uniformity of capsules comprising 50 mg of busulfan for high dose regimens.

Results Intraday and interday variability and imprecision were less than 2.2%.

Conclusions The data indicate high specificity and sensitivity of this novel assay.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.